SCHEMBL9215463

SCHEMBL9215463

Cc1cc(N)c(Cl)c(C)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.48
NCF1 P14598 1/20 0.41
POLB P06746 1/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
ALDH1A1 P00352 3/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CD44 P16070 1/20 0.36
LMNA P02545 2/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
RECQL P46063 1/20 0.35
HSP90AA1 P07900 2/20 0.35
TDP1 Q9NUW8 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
IDO1 P14902 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24293395 0.81 TDP1 (0.44) NR4A2ALDH1A1MAPK1SMN1; SMN2CD44
SCHEMBL30151434 0.81 TDP1 (0.44) NR4A2ALDH1A1MAPK1SMN1; SMN2CD44
SCHEMBL15894463 0.76 NR4A2 (0.46) NR4A2NCF1POLBNOS3NOS1
SCHEMBL29672030 0.76 NR4A2 (0.46) NR4A2NCF1POLBNOS3NOS1
SCHEMBL19047126 0.75 NCF1 (0.43) NR4A2NCF1POLBNOS3NOS1
SCHEMBL9383607 0.75 NCF1 (0.43) NR4A2NCF1POLBNOS3NOS1
SCHEMBL21516636 0.75 ALDH1A1 (0.43) NR4A2POLBALDH1A1MAPK1SMN1; SMN2
SCHEMBL28251597 0.75 LMNA (0.42) NR4A2POLBALDH1A1MAPK1SMN1; SMN2
SCHEMBL26521320 0.74 NR4A2 (0.41) NR4A2NCF1NOS3NOS1NOS2
SCHEMBL31042951 0.73 NR4A2 (0.43) NR4A2NCF1POLBNOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112724134-B Azaindazole bipyridine derivative myeloid cell proliferation inhibitor, preparation method and application thereof in pharmacy 复旦大学 2022-04-01 CN disclosed
CN-113214247-A Azaindole derivative marrow cell proliferation inhibitor, preparation method and application thereof in pharmacy 复旦大学 2021-08-06 CN disclosed
CN-112876456-A Cinnoline compound PI3K kinase inhibitor, preparation method thereof and application thereof in pharmacy 复旦大学 2021-06-01 CN disclosed
CN-112724134-A Azaindazole bipyridine derivative myeloid cell proliferation inhibitor, preparation method and application thereof in pharmacy 复旦大学 2021-04-30 CN disclosed
EP-0520724-B1 Angiotensin II antagonists ZENECA LTD (GB) 1995-09-20 EP disclosed
US-5387592-A Angiotensin converting enzyme inhibitors, calcium channel blockers, diuretics and adrenergic blocking agents IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-02-07 US disclosed
EP-0520723-B1 Angiotensin II antagonists ICI PLC (GB) 1994-06-01 EP disclosed
US-5281613-A Heterocyclic ring substituted benzofuran, benzothiofuran, or indole derivative IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-01-25 US disclosed
US-5236937-A Treating hypertension, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-08-17 US disclosed
EP-0520723-A1 Angiotensin II antagonists IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-12-30 EP disclosed
EP-0520724-A1 Angiotensin II antagonists ZENECA LIMITED (GB) 1992-12-30 EP disclosed
EP-0499415-A1 Pyridine and quinoline derivatives, processes for their manufacture and their use as angiotensin II antagonists ZENECA LIMITED (GB) 1992-08-19 EP disclosed
US-4668675-A ANTIDEPRESSANTS A. H. ROBINS COMPANY, INCORPORATED (US) 1987-05-26 US disclosed
US-4556667-A (2-((AMINOPYRIDINYL)AMINO)PHENYL)ARYLMETHANONE INTERMEDIATES A. H. ROBINS COMPANY, INCORPORATED (US) 1985-12-03 US disclosed
US-4495183-A ANTIULCER AGENTS- GASTROLINTESTINAL DISORDERS A. H. ROBINS COMPANY, INCORPORATED (US) 1985-01-22 US disclosed
US-4447361-A ANTIDEPRESSANT A. H. ROBINS COMPANY, INC. (US) 1984-05-08 US disclosed